Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies

被引：0
|
作者：
El Darsa, Haidar [1 ,2 ]
Massoud, Radwan [1 ,2 ]
Zahreddine, Ammar [1 ,2 ]
Bazarbachi, Ali [1 ,2 ]
El-Cheikh, Jean [1 ,2 ]
机构：
[1] Amer Univ Beirut, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Dept Internal Med, Div Hematol & Oncol, Beirut, Lebanon
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
D O I：
10.1016/j.clml.2017.07.243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RES-133
引用
收藏
页码：S390 / S391
页数：2
相关论文
共 50 条
  • [1] Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies
    El Darsa, Haidar
    Massoud, Radwan
    Haffar, Basel
    Zaherddine, Ammar
    Bazarbachi, Ali
    Elcheikh, Jean
    BLOOD, 2017, 130
  • [2] Sequential chemotherapy associating Thiotepa, Etoposide and Cyclophosphamide followed by reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for the treatment of refractory hematological malignancies
    Rubio, M. T.
    Menard, A. L.
    Malard, F.
    Mamez, A. C.
    Gomez, A.
    Brissot, E.
    Legrand, O.
    Isnard, F.
    Lapusan, S.
    Belhocine, R.
    Ruggeri, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S436 - S437
  • [3] A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies
    Ni, Xiaofei
    Zhai, Weihua
    Pang, AiMing
    Yang, Donglin
    Chen, Xin
    Ma, Qiaoling
    Wei, Jialin
    He, Yi
    Feng, Sizhou
    Han, Mingzhe
    Zhang, Rongli
    Jiang, Erlie
    BLOOD, 2023, 142
  • [4] Sequential Conditioning Regimen with Thiotepa in Allogeneic Hematopoietic Cell Transplantation for the Treatment of Refractory Myeloid Malignancies
    Dulery, Remy
    Belmoufid, Nadia
    Malard, Florent
    Brissot, Eolia
    Banet, Anne
    Sestili, Simona
    Van de Wyngaert, Zoe
    Stocker, Nicolas
    Radici, Vera
    Wieczorek, Michele
    Belhocine, Ramdane
    Lapusan, Simona
    Memoli, Mara
    Genthon, Alexis
    Vekhoff, Anne
    Ledraa, Tounes
    Bonnin, Agnes
    Legrand, Ollivier
    Fenaux, Pierre
    Labopin, Myriam
    Mohty, Mohamad
    BLOOD, 2021, 138 : 1796 - +
  • [5] Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Lee, Kyoungmin
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Ryu, Jin-Sook
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [6] Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia
    刘微
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (03) : 186 - 186
  • [7] Allogeneic bone marrow transplantation in patients with hematological malignancy using busulfan, thiotepa, fludarabine as conditioning regimen
    Raiola, A. M.
    Dominietto, A.
    Varaldo, R.
    Gualandi, F.
    Di Grazia, C.
    Lamparelli, T.
    Bregante, S.
    van Lin, M. T.
    Galaverna, F.
    Ghiso, A.
    Marani, C.
    Bacigalupo, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S221 - S221
  • [8] Regimen related toxicity after thiotepa, cyclophosphamide and intravenous busulfan as conditioning for allogeneic stem cell transplantation
    Sanz, J
    Sanz, GF
    Moscardó, F
    Cupelli, L
    Montesinos, P
    Puig, N
    Lorenzo, I
    Benlloch, L
    Jarque, I
    de la Rubia, J
    Martínez, J
    Martín, G
    Sanz, MA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 33 - 34
  • [9] Fludarabine, busulfan, and thiotepa may be a promising conditioning regimen for myelofibrosis patients undergoing allogeneic stem cell transplantation
    Shouval, Roni
    Vega, Yakov
    Fein, Joshua A.
    Danylesko, Ivetta
    Tov, Noga Shem
    Yerushalmi, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    BONE MARROW TRANSPLANTATION, 2019, 54 : 204 - 205
  • [10] Modified Busulfan and Cyclophosphamide Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Patients With Hematologic Malignancies
    Zhao, X. F.
    Mao, X. F.
    Wan, D. M.
    Liu, W.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (05) : 1531 - 1535
12345